Professur für Molekulare Urologie

The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer (2021) Sikic D, Taubert H, Breyer J, Eckstein M, Weyerer V, Keck B, Kubon J, et al. Journal article Utility of stromal tumor infiltrating lymphocyte scoring (sTILs) for risk stratification of patients with muscle-invasive urothelial bladder cancer after radical cystectomy (2021) Sikic D, Weyerer V, Geppert CI, Bertz S, Lange F, Taubert H, Wach S, et al. Journal article High expression of ERBB2 is an independent risk factor for reduced recurrence-free survival in patients with stage T1 non-muscle-invasive bladder cancer (2021) Sikic D, Eckstein M, Weyerer V, Kubon J, Breyer J, Roghmann F, Kunath F, et al. Journal article Prognostic Role of FGFR Alterations and FGFR mRNA Expression in Metastatic Urothelial Cancer Undergoing Checkpoint Inhibitor Therapy (2021) Tully KH, Jütte H, Wirtz RM, Jarczyk J, Santiago-Walker A, Zengerling F, Breyer J, et al. Journal article Ist die Expression des GP88-Proteins (Progranulin) ein klinisch relevanter Prognosefaktor für Prostatakarzinompatienten? (2021) Taubert H, Eckstein M Journal article Heterogeneity-analysis of molecular subtypes of muscle-invasive bladder cancer and their precursor lesions in multiregion mapped whole-organ bladders (2020) Weyerer V, Lange F, Wullweber A, Stöhr R, Bertz S, Wach S, Taubert H, et al. Conference contribution Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma (2020) Kunz M, Brandl M, Bhattacharya A, Nobereit-Siegel L, Ewe A, Weirauch U, Hering D, et al. Journal article Mitophagy-associated genes PINK1 and PARK2 are independent prognostic markers of survival in papillary renal cell carcinoma and associated with aggressive tumor behavior (2020) Simon AG, Tolkach Y, Esser LK, Ellinger J, Stoehr C, Ritter M, Wach S, et al. Journal article Loss of RBMS1 as a regulatory target of miR-106b influences cell growth, gap closing and colony forming in prostate carcinoma (2020) Dankert JT, Wiesehöfer M, Wach S, Czyrnik ED, Wennemuth G Journal article, Original article CREB1 is affected by the microRNAs miR-22-3p, miR-26a-5p, miR-27a-3p, and miR-221-3p and correlates with adverse clinicopathological features in renal cell carcinoma (2020) Friedrich M, Heimer N, Stoehr C, Steven A, Wach S, Taubert H, Hartmann A, Seliger B Journal article, Original article